These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 3521766)

  • 1. Cytogenetic studies in bone marrow transplant recipients.
    Haas OA; Hinterberger W; Schmidmeier W; Pollak C; Hinterberger M; Gadner H; Lechner K
    Blut; 1986 Jul; 53(1):29-38. PubMed ID: 3521766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytogenetic correlation with disease status and treatment outcome in advanced stage leukemia post bone marrow transplantation: a Southwest Oncology Group study (SWOG-8612).
    Slovak ML; Kopecky KJ; Wolman SR; Henslee-Downey JP; Appelbaum FR; Forman SJ; Blume KG
    Leuk Res; 1995 Jun; 19(6):381-8. PubMed ID: 7596150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experience with bone marrow transplantation for severe aplastic anemia and leukemia. Two years experience with 31 patients in Zagreb (Yugoslavia).
    Labar B; Bogdanic V; Kastelan A; Vrtar M; Grgic-Markulin L; Balabanic-Kamauf B; Francetic I; Dobric I; Grgicevic D; Kerhin-Brkljacic V
    Biomed Pharmacother; 1986; 40(9):332-7. PubMed ID: 3548836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bone marrow transplantation in acute leukemia, chronic myeloid leukemia, severe aplastic anemia and stage IV neuroblastoma. Effect of antiviral prevention with anti-CMV-hyperimmunoglobulin and acyclovir].
    Ostendorf P; Ehninger G; Dopfer R; Schmidt H; Haen M; Link H; Schüch K; Müller CA; Wernet P; Klingebiel T
    Klin Wochenschr; 1986 May; 64(10):453-66. PubMed ID: 3014203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic applications of allogeneic BMT: aplastic anemia and the leukemias.
    Oblon DJ; Weiner RS; Mackin PJ
    J Fla Med Assoc; 1984 May; 71(5):329-35. PubMed ID: 6376696
    [No Abstract]   [Full Text] [Related]  

  • 6. Allogeneic bone marrow transplantation in the treatment of hematologic diseases.
    Yee GC; McGuire TR
    Clin Pharm; 1985; 4(2):149-60. PubMed ID: 3886273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonogenic hemopoietic precursors in bone marrow transplantation.
    Messner HA; Curtis JE; Minden MD; Tritchler D; Lockwood G; Takahashi T; Lepine J; Jamal N; Tweeddale M; Wandl U
    Blood; 1987 Nov; 70(5):1425-32. PubMed ID: 3311204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of graft-versus-host disease as immunotherapy of leukemia relapsing after allogeneic transplantation: single-center experience of 32 adult patients.
    Mehta J; Powles R; Kulkarni S; Treleaven J; Singhal S
    Bone Marrow Transplant; 1997 Jul; 20(2):129-35. PubMed ID: 9244416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of herpes simplex virus (HSV) infection in recipients of HLA-matched T-lymphocyte-depleted bone marrow allografts.
    Engelhard D; Morag A; Or R; Naparstek E; Cividalli G; Ruchlemer R; Aker M; Maayan S; Slavin S
    Isr J Med Sci; 1988 Mar; 24(3):145-50. PubMed ID: 3286577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytogenetics and bone marrow transplantation.
    Palka G; Di Bartolomeo P; Iacone A; Di Girolamo G; Betti S; Calabrese G; Natale D; Stuppia L; Rieve AK; Torlontano G
    Cancer Genet Cytogenet; 1986 Mar; 21(2):147-57. PubMed ID: 3512073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone marrow transplantation for leukemia and aplastic anemia: management of ABO incompatibility.
    Curtis JE; Messner HA
    Can Med Assoc J; 1982 Mar; 126(6):649-55. PubMed ID: 7039802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytogenetic studies on recipients of allogeneic bone marrow using the sex chromosomes as markers of cellular origin.
    Lawler SD; Baker MC; Harris H; Morgenstern GR
    Br J Haematol; 1984 Mar; 56(3):431-43. PubMed ID: 6365153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Marrow transplantation in treatment of children with aplastic anaemia or acute leukaemia.
    Johnson FL; Hartmann JR; Thomas ED; Chard RL; Hersman JA; Buckner CD; Clift RA; Storb R
    Arch Dis Child; 1976 Jun; 51(6):403-10. PubMed ID: 8016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colony growth in cultures from bone marrow and peripheral blood after curative treatment for leukemia and severe aplastic anemia.
    Betticher DC; Huxol H; Müller R; Speck B; Nissen C
    Exp Hematol; 1993 Nov; 21(12):1517-21. PubMed ID: 8405233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allogeneic bone marrow transplantation using unrelated donors: a pilot study of the Canadian Bone Marrow Transplant Group.
    Phillips GL; Barnett MJ; Brain MC; Chan KW; Huebsch LB; Klingemann HG; Meharchand J; Reece DE; Rybka WB; Shepherd JD
    Bone Marrow Transplant; 1991 Dec; 8(6):477-87. PubMed ID: 1790428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recipients of HLA-identical sibling marrow transplants with severe aplastic anemia engraft more quickly, and those with chronic myeloid leukemia more slowly, than those with acute leukemia.
    Atkinson K; Downs K; Ashby M; Dodds A; Concannon A; Biggs J
    Bone Marrow Transplant; 1989 Jan; 4(1):23-7. PubMed ID: 2647183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclosporin-A in allogeneic bone marrow transplantation for leukemia: Basle experience 1979 to 1984.
    Gratwohl A
    Tokai J Exp Clin Med; 1985 Jun; 10(2-3):127-32. PubMed ID: 3914737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of allogeneic bone marrow transplantation for acute leukemia have improved in Europe with time--a report of the acute leukemia working party of the European group for blood and marrow transplantation (EBMT).
    Frassoni F; Labopin M; Gluckman E; Prentice HG; Vernant JP; Zwaan F; Granena A; Gahrton G; De Witte T; Gratwohl A; Reiffers J; Gorin NC
    Bone Marrow Transplant; 1996 Jan; 17(1):13-8. PubMed ID: 8673048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry.
    Socié G; Stone JV; Wingard JR; Weisdorf D; Henslee-Downey PJ; Bredeson C; Cahn JY; Passweg JR; Rowlings PA; Schouten HC; Kolb HJ; Klein JP
    N Engl J Med; 1999 Jul; 341(1):14-21. PubMed ID: 10387937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Donor cell-derived acute myeloid leukemia developing 14 months after matched unrelated bone marrow transplantation for chronic myeloid leukemia.
    Hambach L; Eder M; Dammann E; Battmer K; Stucki A; Heil G; Ganser A; Hertenstein B
    Bone Marrow Transplant; 2001 Oct; 28(7):705-7. PubMed ID: 11704795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.